Remodelling and Inhibition of Energy Metabolism during the Mitochondrial Life Cycle of Trypanosomatid Parasites

Description of the granted funding

Trypanosomatid parasites cause lethal diseases, such as visceral leishmaniasis and Chagas disease, infecting ~7 million people worldwide. Available drugs for these diseases suffer from severe toxic side effects and emergence of drug resistance. The mitochondrion, the powerhouse of the cell, harbours an energy-converting protein machinery called complex III, which is essential for parasite survival and a confirmed drug target, but its three-dimensional structure is unknown. Using tomographic methods at the electron microscopy unit of the University of Helsinki, we will determine how the parasite achieves a tight packing of complex III molecules inside its powerhouse. Using high-resolution electron microscopy, we will determine the molecular structure of complex III bound to anti-trypanosomatid inhibitors to reveal how they block the protein complex. This project will expand our understanding of a fundamental cell biological process in human parasites and inform future drug development.
Show more

Starting year

2025

End year

2029

Granted funding

Alexander Mühleip Orcid -palvelun logo
599 747 €

Funder

Research Council of Finland

Funding instrument

Academy projects

Decision maker

Scientific Council for Biosciences, Health and the Environment
16.06.2025

Other information

Funding decision number

371050

Fields of science

Biochemistry, cell and molecular biology

Research fields

Biokemia, biofysiikka

Identified topics

molecular biology, biochemistry